Modified Norwood procedure with a high-flow cardiopulmonary bypass strategy results in low mortality without late arch obstruction  by Poirier, Nancy C. et al.
T he prospects for patients with hypoplastic left heartsyndrome (HLHS) and similar anatomic variants
were dramatically altered with the introduction of a
staged palliative approach as described by Norwood
and colleagues.1 The first stage involves the creation of
an unobstructed communication between the systemic
right ventricle through a reconstructed aorta and arch
with a controlled source of pulmonary blood flow
through a systemic-pulmonary shunt.1-3 As the child
outgrows the arterial shunt and the pulmonary vascular
resistance decreases, a bidirectional cavopulmonary
shunt (BCPS) is performed and the Fontan operation, or
a variant thereof, is completed as a final procedure. This
Objective: The results of our modification of the stage I Norwood procedure,
in which we use only autologous tissue to reconstruct the aortic arch, were
reviewed. A high-flow, low-pressure cardiopulmonary bypass protocol (with
phenoxybenzamine), before and after a period of deep hypothermic circula-
tory arrest, was used.
Methods: Between 1993 and 1999, 59 patients, aged 1 to 353 days (median
4 days) and weighing 1.7 to 6.8 kg (median 3.2 kg), underwent a modified
Norwood procedure. The ascending aortic diameter ranged from 1.5 to 8 mm
(median 3 mm). The modified Blalock-Taussig shunt was 3 mm in 21
patients (36%) and 3.5 mm or larger in 38 patients (64%).
Results: Deep hypothermic circulatory arrest and cardiopulmonary bypass
times ranged from 15 to 64 minutes (median 37 minutes) and 44 to 144 min-
utes (median 88 minutes), respectively. Early postoperative survival was
83%. By univariate analysis, early mortality was associated with an ascend-
ing aortic diameter of 2.5 mm or less (P = .01). Weight, circulatory arrest and
bypass times, diagnosis (hypoplastic left heart syndrome vs variant), shunt
size, and date of the procedure did not affect survival. For a median follow-
up period of 37 months (range 4-63 months), 42 (61%) patients underwent
bidirectional cavopulmonary shunts, 10 (17%) had Fontan operations, and 1
patient underwent transplantation after a bidirectional cavopulmonary shunt.
Eight patients subsequently died, for a 1-year actuarial survival of 72% (95%
confidence interval: 60%-84%). Neoaortic arch obstruction was corrected in
3 patients (5%).
Conclusions: At intermediate-term follow-up, our modification of the
Norwood procedure together with our perioperative strategies has resulted in
acceptable outcomes with a low incidence of neoaortic arch obstruction.
Patients with a small ascending aortic diameter have emerged as a high-risk
group, but a recent technical modification may improve the outlook for these
patients.  (J Thorac Cardiovasc Surg 2000;120:875-84)
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staged approach is an attractive alternative to primary
cardiac transplantation. 
The Norwood procedure, however, remains challeng-
ing, with a relatively high early and late mortality. The
“classic” Norwood procedure, in which the ascending
aorta and arch are augmented with homograft material,
has a reported incidence of arch obstruction of 14% to
33% due to lack of growth, calcification, and degener-
ation.4-6 Branch pulmonary artery obstruction from a
redundant reconstructed arch has also been reported.7
Our modification of the Norwood procedure consists
of augmenting the arch by means of a combined anas-
tomosis of the proximal main pulmonary artery (MPA)
to the arch and descending aorta, without the use of for-
eign material.8 In addition to the technical modifica-
tion, the perioperative strategy has evolved and features
high-flow, low-pressure perfusion made possible with
the use of phenoxybenzamine, judicious management
of fluid balance, a low threshold for peritoneal dialysis,
and ventilation customized to the physiology of the
patient.
The early and intermediate results of our therapeutic
strategy for HLHS and its variants are presented here.
Patients and methods
Patients.  Between August 1993 and July 1999, 59 consec-
utive infants (37 boys and 22 girls) with HLHS or a variant of
HLHS underwent a modified Norwood procedure. The medi-
an age at operation was 4 days (range 1-353 days, mean 19 ±
59 days), including 4 patients older than 2 months (74, 79,
288, and 353 days). Five infants were premature, the
youngest born after 31 weeks of gestation. The median
weight was 3.2 kg (range 1.7-6.8 kg, mean 3.3 ± 0.81 kg). 
Forty-seven patients (80%) had HLHS, defined as mitral
and aortic stenosis or atresia (or both) in the presence of nor-
mally related great vessels, a hypoplastic left ventricle, and
an intact ventricular septum. Patients who did not conform to
these criteria but who had a duct-dependent parallel circula-
tion, with a nonseptatable heart and left ventricular outflow
tract obstruction, were considered to have variants of HLHS.
The anatomic features of the HLHS variants are listed in
Table I. 
An aberrant right subclavian artery was encountered in 4
patients. The coronary sinus was unroofed in 2 of the 5
patients with a persistent left superior vena cava. An inter-
rupted aortic arch was present in 4 patients. Associated
lesions are listed in Table II.
The diameter of the ascending aorta was measured by
echocardiogram before the operation and verified during the
operation. The diameters of the ascending aorta ranged from
1.5 to 8 mm (median 3 mm; mean 3.5 ± 1.6 mm). Twenty-
four patients had an ascending aorta measuring 2.5 mm or
smaller. Antegrade flow in the ascending aorta was absent in
27 patients (46%). The mitral valve was atretic in 19 patients
(32%). 
Tricuspid or atrioventricular valve regurgitation (TR) was
documented with color flow Doppler echocardiography. TR
was described as trace or mild in 45 patients (76%), moder-
ate in 11 (19%), and severe in 1 (2%). Only 1 patient had a
preoperative balloon atrial septostomy at another institution. 
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Table I.  HLHS variants: Anatomic features
Diagnosis No. of patients (n = 12)
HLHS and VSD 1
Unbalanced CAVC 2
Complex DORV 4
TA and TGA 2
DILV and TGA 3
LA isomerism 2
HLHS, Hypoplastic left heart syndrome; CAVC, complete atrioventricular
canal; DORV, double-outlet right ventricle; TA, tricuspid atresia; TGA, trans-
position of the great arteries; DILV, double-inlet left ventricle; LA, left atrial.
Table II. Associated lesions (n = 12)
Lesion No.
Persistent LSVC 5
Aberrant RSCA 4
ALCARPA 1
PAPVR 1
TAPVR 1
LSCV, Left superior vena cava; RSCA, right subclavian artery; ALCAPA,
anomalous left coronary artery from right pulmonary artery; PAPVD, partial
anomalous pulmonary venous drainage; TAPVD, total anomalous pulmonary
venous drainage.
Fig 1. The modified Norwood procedure: The ascending
aorta, arch, descending aorta, and brachiocephalic arteries
were completely mobilized. The MPA was transected
obliquely, proximal to the right and left pulmonary arteries. 
Preoperatively, 47 patients (80%) were in stable condition
with good peripheral perfusion and little or no acidosis. The
other 12 patients (20%) had severe hemodynamic instability
with systemic malperfusion and end-organ failure.
Necrotizing enterocolitis developed preoperatively in 1
patient, and surgery was postponed while he was medically
managed. Fifty-one patients (86%) received mechanical ven-
tilation before the operation, intubated either electively or
due to hemodynamic instability. Alprostadil (prostaglandin
E1) was administered preoperatively in all but the 4 patients
who presented after 2 months of age. Preoperative inotropic
support was required in 26 patients (44%). All patients were
subjected to ultrasound evaluation of the head and abdomen
before undergoing the modified Norwood procedure. 
Perfusion protocol.  The perfusion protocol was standard-
ized. Methylprednisolone (20 mg/kg) was administered
before cardiopulmonary bypass (CPB). Fresh, heparinized
whole blood was used in the CPB prime. Phenoxybenzamine
(0.25 mg/kg) facilitated vasodilation necessary to allow high
perfusion flow (greater than 150 mL · kg–1 · min–1) before and
after the period of circulatory arrest. Perfusion pressures were
maintained at 30 to 35 mm Hg and body temperatures were
cooled to 18°C (nasopharyngeal).
Operative technique.  A median sternotomy and subtotal
thymectomy were performed, exposing the pericardium,
which was harvested for the reconstruction of the pulmonary
artery confluence. CPB was established with the arterial can-
nula placed in the ductus arteriosus (double cannulation for
an interrupted aortic arch) and a single right atrial venous
cannula. The ascending aorta, arch, descending aorta, and
brachiocephalic arteries were completely mobilized. The
main pulmonary artery was transected obliquely, proximal to
the origins of the right and left pulmonary arteries (Fig 1).
The distal MPA was closed with a fresh, autologous pericar-
dial patch. A modified Blalock-Taussig shunt was fashioned
with a polytetrafluoroethylene (PTFE) tube graft and the
proximal anastomosis on the distal innominate artery was
completed during cooling. A 3-mm PTFE tube graft was used
in 20 patients (34%), a 3.5-mm graft in 34 (58%), and a clas-
sic Blalock-Taussig shunt was performed in a 1.7-kg child.
Among the 4 older patients, 3 received a 4-mm PTFE tube
graft and the fourth received a 5-mm PTFE tube graft.
Deep hypothermic circulatory arrest (DHCA) was institut-
ed at 18°C, and the cannulas were removed after the heart
was arrested with a single dose of crystalloid cardioplegic
solution delivered through the arterial cannula. All ductal tis-
sue was resected, and the lesser curvature of the arch was
opened from the left subclavian artery to the ascending aorta
(Fig 2). In 43 patients (73%) this incision was extended at the
level of the innominate artery in the patients in whom the
diameter of the ascending aorta was larger or to the mid-
ascending aorta when the ascending aorta was smaller. The
arch was reconstructed by anastomosis of the descending
aorta to the aortic isthmus and distal arch. The proximal MPA
was then anastomosed to a combination of ascending aorta,
proximal arch, and descending aorta.
Concerns with the anastomosis of the MPA to a small
ascending aorta have resulted in a series of modifications of
this technique (Figs 3 to 5). In 16 patients, the ascending
aorta was transected and shortened. It was then reimplanted
onto the innominate artery in 7 patients, the posterior MPA in
3, and the right anterior sinus of the MPA in 6 patients. 
A radical atrial septectomy was then performed through the
right atrial cannulation site. CPB flow was restarted and
rewarming was begun, during which time the distal anasto-
mosis of the modified Blalock-Taussig shunt was completed. 
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Fig 2. The modified Norwood procedure (continued): A, Once all of the ductal tissue was resected, the lesser cur-
vature of the arch was opened from the left subclavian artery to the ascending aorta. B, The arch was reconstruct-
ed by anastomosis of the descending aorta to the aortic isthmus and distal arch. The proximal MPA was then
sutured to a combination of ascending aorta, proximal arch, and descending aorta.
A B
An intracardiac monitoring line was placed in the left atri-
um. After administration of protamine, a peritoneal dialysis
catheter was inserted. Before the patient was weaned from
CPB, dopamine (5 µg · kg–1 · min–1) and nitroglycerin (5 µg
· kg–1 · min–1) were started. Norepinephrine (0.1-0.4 µg · kg–1
· min–1) was added if systemic vasodilation due to the phe-
noxybenzamine was excessive. The chest was closed in all
but 9 patients (15%), in whom there were intraoperative
hemodynamic changes. The sternum was subsequently closed
at a median of 2.5 days after the operation (range 2-4 days).
Postoperative management. Patients were kept sedated and
paralyzed during the initial 24 hours. Ventilatory adjustments
were used to balance pulmonary and systemic blood flows. A
pressure-regulated volume-controlled mode of ventilation was
used. Initial settings included a rate of 20 to 25 breaths/min, a
positive end-expiratory pressure of 4 to 6 cm H2O, and a pre-
set tidal volume of 12 mL/kg. Ventilatory goals were a normal
pH and an arterial carbon dioxide level between 35 and 45 mm
Hg. The inspired oxygen fraction was adjusted to maintain
transcutaneous oxygen saturations between 70% and 80% and
an arterial oxygen level of 35 to 45 mm Hg. If and when the
oxygen saturation was consistently above 80% with the patient
breathing room air, the preset tidal volume was then decreased
to maintain a mild respiratory acidosis, and the arterial carbon
dioxide level was kept between 45 and 55 mm Hg. Hypoxic
admixtures were not used in any of our patients. In the presence
of high pulmonary vascular resistance and desaturation, nitro-
glycerin infusion was then combined with alprostadil or
inhaled nitric oxide (or both). 
Peritoneal dialysis administered by a previously described
technique9 was instituted for decreased urine output or
increased serum potassium levels. 
All patients received anticoagulation in the form of heparin
(10 units · kg–1 · h–1) for the initial 48 hours, and long-term
acetylsalicylic acid (5 mg/kg every other day) was begun on
postoperative day 1. Feeding was begun gradually, first in the
form of continuous feeds, followed by gavage feeding through
a nasogastric tube, and finally oral feeding was begun as tol-
erated. Strict attention to fluid balance and homeostasis was
maintained in the early postoperative period. 
BCPS and Fontan operations. Before BCPS and Fontan
operations, an echocardiogram and cardiac catheterization
were obtained. Both procedures were performed through a
median sternotomy with CPB, without circulatory arrest. The
pulmonary arteries were augmented with fresh autologous
pericardium in the presence of stenoses. 
The Fontan operation was performed at approximately 3 to 5
years of age with the development of activity-limiting exercise
intolerance or cyanosis. A lateral tunnel Fontan was created by
means of a PTFE patch with a 3- to 4-mm fenestration. 
Statistical methods. Clinical and follow-up data were
retrieved from medical records. Statistical analysis was
obtained by means of Statistica 4.0 software (StatSoft, Inc,
Tulsa, Okla). Early postoperative death was defined as occur-
ring within 30 days of the modified Norwood procedure or
during the same hospitalization. The data are reported as a
median, range, and/or mean ± standard deviation. 
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Fig 3. The modified Norwood procedure—the first modifi-
cation: In 7 patients, the ascending aorta was transected,
shortened, and reimplanted onto the proximal innominate
artery. There were 3 late deaths at 1.5, 2, and 3 months post-
operatively, possibly due to coronary steal from the adjacent
modified Blalock-Taussig shunt.
Fig 4. The modified Norwood procedure—the second modi-
fication: The ascending aorta was shortened and implanted
onto the posterior face of the main pulmonary artery, which
would preserve the lie of the ascending aorta. This was
quickly abandoned after early deaths in 2 of the 3 patients
who underwent this procedure. Myocardial ischemia by
compression of the ascending aorta was believed to be the
culprit. 
The significance of continuous variables on early mortality
was determined by means of the Mann-Whitney rank sum
test. Categoric variables were analyzed with the use of a χ2
test or a Fisher exact 2-tailed test if one of the numerators of
a proportion was equal to or less than 5 events. 
The actuarial survival was estimated by a Kaplan-Meier
method and 95% confidence limits (95% CI) were stated. The
attrition rate was centered around the first 5 months after the
modified Norwood procedure. The effect of the variables
analyzed for early postoperative mortality was also calculat-
ed for the intermediate postoperative mortality. Univariate
analysis of continuous variables was therefore performed by
means of the Cox proportional hazard regression model, and
categoric variables underwent a log-rank test.
Results
DHCA and CPB times ranged from 15 to 64 minutes
(median 37 minutes, mean 39 ± 9 minutes) and 44 to
144 minutes (median 88 minutes, mean 96 ± 24 min-
utes), respectively. 
The early postoperative survival was 83% (49/59).
An autopsy was obtained in 5 of the 10 patients who
died. In 2 patients a transmural infarct of the right and
left ventricles was observed. Ischemic myocardial
changes were observed in a patient who died of a post-
operative respiratory syncytial virus infection and tam-
ponade. A clotted shunt was found in 1 patient and a
severely dysplastic tricuspid valve in another.
Early reinterventions were necessary in 9 patients
(15%) with 2 early deaths. Indications for reoperation
included pericardial effusion in 2 patients (3%), tam-
ponade in 3 (5%) after removal of intracardiac lines or
pacing wires, and shunt thrombosis in 2 (3%). Revision
of the neoaortic arch was required within 24 hours of
the initial operation in 2 patients (3%). Extracorporeal
membrane oxygenation was instituted after postopera-
tive cardiac arrest in 3 patients, all of whom were suc-
cessfully weaned and discharged from the hospital.
One of the 3 patients died suddenly 3 months after the
operation, another is developmentally delayed, and the
third patient is doing well, with a slight decrease in fine
motor skills, and is soon to be evaluated for a Fontan
procedure. 
Postoperative complications included sepsis in 13
(22%) patients (including mediastinitis in 2 patients
[3%]), supraventricular tachyarrhythmia in 4 (7%),
chylothorax lasting more than 1 week in 1 patient (2%),
and medically treated necrotizing enterocolitis in 1
patient (2%). Four patients had seizures during the
postoperative period, including the 3 patients who had
a cardiac arrest, were resuscitated, and were supported
temporarily with extracorporeal membrane oxygena-
tion. Diaphragmatic palsy was identified in 2 patients,
resolving in 1, and 2 other patients had recurrent laryn-
geal nerve paralysis, with 1 patient requiring a tra-
cheostomy for upper airway obstruction. 
The median hospital stay was 13 days (range 7-112
days, mean 19 ± 17 days). The median stay in the crit-
ical care unit was 7 days (range 3-99 days, mean 12 ±
15 days), and duration of mechanical ventilation was a
median of 5 days (range 1-28 days, mean 6.7 ± 5.8
days). 
Variables evaluated as potential risk factors for early
mortality are listed in Tables III and IV. The size of the
ascending aorta (P = .05) and the absence of antegrade
flow (P = .004) through the aortic valve have a signifi-
cant impact on postoperative mortality. Of the 24
patients with a small ascending aorta diameter (≤2.5
mm), 8 or 33% died. In contrast, only 2 of the 35
patients (5.7%) with an ascending aorta diameter larg-
er than 2.5 mm died (P = .01). The 1- and 4-year actu-
arial survivals for patients with a small ascending aorta
are 50% (95% CI: 30%-70%) at both time points.
Patients with an ascending aorta more than 2.5 mm in
diameter had an actuarial survival at 1 and 4 years of
88% (95% CI: 77%-99%) and 80% (95% CI: 62%-
98%), respectively (P = .006; Fig 6).
During the initial experience, the ascending aorta
was left in situ regardless of the size of the ascending
aorta. The early mortality in 13 patients with a small
ascending aorta with this technique was 38%. Since
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Fig 5. The modified Norwood procedure—the third modifi-
cation: The ascending aorta was anastomosed onto the anteri-
or rightward sinus of the MPA. Between August 1993 and
July 1999, 6 patients underwent this last modification, which
was performed with a shortened ascending aorta. One early
death and no late deaths were recorded. From July 1999 to
March 2000, 7 other patients have had a full-length ascending
aorta implanted onto the anterior MPA with 1 early death.
then, 3 modifications of the technique have been per-
formed in 16 patients, aimed at reducing the mortality
in this high-risk group. Results of individual reimplan-
tation techniques are shown in Figs 3 to 5. The ascend-
ing aorta was shortened for these modifications. The
first modification with reimplantation onto the innomi-
nate artery was associated with 3 late deaths (n = 7) at
1.5, 2, and 3 months after the modified Norwood pro-
cedure. The hypothesis was coronary steal from the
adjacent modified Blalock-Taussig shunt. The second
modification involved implantation of the ascending
aorta onto the posterior face of the MPA, which would
preserve the lie of the ascending aorta. This was quick-
ly abandoned after 2 early deaths (n = 3). Myocardial
ischemia by compression of the ascending aorta was
believed to be the culprit. The last modification con-
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Table III.  Univariate predictors of early and intermediate postoperative mortality: Continuous variables
P values
Mortality variable Median Range Early mortality Intermediate mortality
Age (d) 4.0 1-353 .05 .01
Ascending aorta diameter (mm) 3.0 1.5-8.0 .02 .006
Weight (kg) 3.2 1.7-6.8 .89 .46
Circulatory arrest time (min) 37 15-64 .36 .13
CPB (min) 88 56-144 .43 .49
CPB, Cardiopulmonary bypass time.
Table IV.  Univariate predictors of early and intermediate postoperative mortality: Categoric variables
Early mortality Intermediate mortality
Variable n % P value % P value
Age
<3 d 9 44 .03 56 .02
≥3 d 50 12 26
Age
<5 d 27 22 .49 41 .07
≥5 d 32 12 22
Sex
Male 37 19 .73 32 .36
Female 22 14 27
Weight
<3 kg 20 15 1.00 35 .34
≥3 kg 39 18 28
Ascending aorta diameter
≤2.5 mm 24 33 .01 50 .006
>2.5 mm 35 5.7 17
Aortic atresia 27 33 .004 52 .0001
Aortic stenosis 32 3.1 12
Mitral atresia 19 32 .06 58 .004
Mitral stenosis 40 10 18
HLHS 47 21 .10 36 .11
HLHS variant 12 0 8
Preop TR
≤Mild 45 11 .05 24 .05
>Mild 14 36 50
Shunt
3 mm 20 15 1.0 40 .31
≥3.5 mm 38 18 26
Preop end-organ failure 12 8.3 .67 25 .18
Era
1993-1996 29 10 .29 31 .27
1997-1999 30 23 30
HLHS, Hypoplastic left heart syndrome; Preop TR, perioperative tricuspid and atrioventricular valve regurgitation.
sisted of the implantation of the ascending aorta onto
the rightward and anterior sinus of the MPA. Among
the 6 patients subjected to this last modification, there
has been 1 early death and no late mortality. From July
1999 to March 2000, there have been 7 other patients
in whom the full-length ascending aorta has been anas-
tomosed to the anterior MPA. A single patient with
documented myofibrillar myopathy has died. 
Age at operation was found to affect postoperative
mortality (P = .05). Nine patients underwent surgery at
less than 3 days of age, and of these 4 died after the
operation (P = .03). All early postoperative deaths were
in patients aged less than 7 days at operation.
Preoperative TR (moderate and severe) is also predic-
tive of postoperative death (P = .05). Two other predic-
tors of mortality beyond the early postoperative period
were TR of greater than a mild degree and younger age. 
The use of a 3.0-mm modified Blalock-Taussig shunt
had no effect on the overall intermediate-term postop-
erative mortality. Interestingly, preoperative shock and
end-organ failure were not significant predictors of
early mortality (P = .67). The size of the modified
Blalock-Taussig shunt, anatomic diagnosis (variant vs
nonvariant), weight, DHCA and CPB times, as well as
the era (before and after 1996), were not associated
with early mortality (Tables III and IV). There were no
early deaths in the 4 patients with an aberrant right sub-
clavian artery who had the modified Blalock-Taussig
shunt placed onto the right carotid artery. 
During a median follow-up period of 37 months
(range 4-66 months), there were 8 deaths, 6 of which
were during the first year of life, resulting in 1- and 4-
year actuarial survivals estimated at 72% (95% CI:
60%-84%) and 68% (95% CI: 74%-82%), respectively
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Fig 6. Actuarial survival after the modified Norwood procedure according to ascending aorta size. Ninety-five per-
cent confidence limits are stated. n, Number of patients; AAo, ascending aorta diameter.
Fig 7. Overall actuarial survival after the modified Norwood procedure. Ninety-five percent confidence lim-
its are stated; n, number of patients.
(Fig 7). Postmortem examinations were not obtained in
these patients. Five deaths occurred before BCPS (Fig
8). Two patients were clinically well and died sudden-
ly, 1 had severe TR and was scheduled for tricuspid
valve repair and BCPS, and 1 child died of respiratory
complications associated with a documented respirato-
ry syncytial virus. One child aged 3 months died 3 days
after balloon dilatation of an ascending aorta/neoaortic
suture line stenosis. Two other patients underwent suc-
cessful balloon dilatation for a 15– and 30–mm Hg gra-
dient at the level of the anastomosis between the MPA
and descending aorta. There has been no restenosis 2.5
and 3 years later. 
Forty-two patients underwent BCPS at a median age
of 5 months (range 3-20 months, mean 5.7 ± 27
months). One patient died early of complications from
mediastinitis and renal failure. The 1 late death after
BCPS was due to accidental head trauma a few days
before a scheduled Fontan operation. Cardiac trans-
plantation was performed 2 years after BCPS in 1 child
who was unsuitable for a Fontan operation due to
severe right ventricular failure. 
Ten patients have undergone a fenestrated Fontan
procedure at a median age of 4.1 years (range 2.5-5.1
years). The median aortic crossclamp time was 39 min-
utes (range 23-51 minutes) and the median CPB time
was 82 minutes (range 63-132 minutes). One patient
with progressive right ventricular failure died suddenly
3 years after the Fontan operation. 
Postoperative echocardiographic data were available
in all survivors. The last evaluation was performed at a
median of 18 months (range 4-62 months, mean 26 ±
21 months) after the modified Norwood procedure. TR
was mild, trace, or absent in 33 children (80%), moder-
ate in 6 (14.6%), and severe in 1 patient (2%).
Tricuspid annuloplasties have been performed in 7 of
59 patients (12%), 2 at the modified Norwood proce-
dure, 3 at the BCPS, and 2 at the Fontan operation. No
operative deaths occurred in this group of patients and
only 1 patient has TR necessitating re-repair at a sub-
sequent staged procedure. Only 1 patient underwent
balloon dilation of the left pulmonary artery 2 years
after BCPS and underwent a successful Fontan proce-
dure 3 months later. Pulmonary artery patch recon-
struction was performed at BCPS or the Fontan opera-
tion if the patency of the branch pulmonary arteries was
in doubt. 
Comment
Staged reconstruction for HLHS and HLHS variants
has resulted in variable outcomes, with reported 5-year
actuarial survivals of 20% to 69%.6,10-14 Most deaths
occur in the first year of life, particularly before the
BCPS. Since the first descriptions of the Norwood pro-
cedure as part of a staged reconstruction protocol, a
number of technical modifications have been devel-
oped in an attempt to improve outcomes. Advances in
surgical technique, small-body perfusion technology,
and perioperative management by a multidisciplinary
team have resulted in improved survival for this diffi-
cult group of patients.
The modified Norwood procedure was possible in all
patients without the use of patch augmentation even in
the presence of an interrupted aortic arch. A tension-
free reconstruction is possible by extensively mobiliz-
ing the descending aorta, arch, and brachiocephalic
arteries. The longitudinal split of the medial descend-
ing aorta and the use of as much MPA length as possi-
ble are technical aspects that further reduce tension on
the anastomosis. 
At intermediate follow-up, our modification of the
Norwood technique achieves results comparable with
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Fig 8. Intermediate follow-up of the modified Norwood procedure. BCPS, Bidirectional cavopulmonary shunt.
those reported for the standard Norwood operation.10-14
Early postoperative survival of the 36 patients with an
ascending aorta larger than 2.5 mm is 94.3%. The 1-
and 4-year actuarial survivals of 88% and 80% are cer-
tainly acceptable. However, early on in this series it
became evident that a small ascending aorta (≤2.5 mm)
was a risk factor with this technique. The high opera-
tive mortality associated with a small ascending aorta is
not unique to our series and has been observed by other
authors using both a patch augmentation to reconstruct
the arch13,14 and the modified Norwood technique.6
A number of modifications of the aortic reimplanta-
tion technique were attempted before we accepted the
present approach. This method of reimplantation uses
the full length of the small ascending aorta anasto-
mosed end to side into the anterior and rightward
aspect of the proximal MPA at the level of the sino-
tubular junction. The early postoperative mortality in
this high-risk group appears to have been substantially
reduced, but the numbers are small, follow-up is short,
and further evaluation is necessary. 
Advantages of the modified Norwood procedure
include a low incidence of neoaortic/arch obstruction,
avoidance of foreign material, a low incidence of left
pulmonary artery compression, and shorter DHCA
times.10,11 These factors are also essential to satisfacto-
ry intermediate and long-term results, providing condi-
tions favorable for a successful BCPS and subsequent
Fontan candidacy. 
Anatomic features would appear by association to
influence outcomes. A small ascending aorta invariably
accompanies aortic and mitral atresia. The presence of
substantial TR before the modified Norwood procedure
may be indicative of ventricular dysfunction, possibly
due to myocardial ischemia. In our series, the presence
of an aberrant right subclavian artery and modified
Blalock-Taussig shunt originating from the right
carotid artery was not associated with an increased
operative mortality, as reported by Ishino and associ-
ates,6 using a similar modified Norwood technique.
Furthermore, we did not find the diagnosis of an HLHS
variant to be associated with a lower operative mortal-
ity, as reported by Daebritz and colleagues.11
The increased number of early postoperative deaths
seen in patients aged less than 7 days is worrisome.
This group of patients was in hemodynamically stable
condition before the operation, with good systemic per-
fusion. We suspect that the labile pulmonary vascular
circuit, which is normally seen in the first week of life,
may have led us to use a larger modified Blalock-
Taussig shunt, making postoperative management dif-
ficult and translating into an unfavorable outcome. A
larger cohort of patients would allow for a meaningful
multivariate analysis to determine the true impact of
age on the perioperative mortality.
The small number of patients in our study precludes
statistical analysis of the relative contributions of the
anatomic variants, technical details, and perioperative
management to the operative mortality. The long-term
neurologic outcome of these patients is of concern and
presently the subject of ongoing studies. 
In conclusion, at intermediate-term follow-up, the
combination of our modification of the Norwood pro-
cedure together with meticulous perioperative manage-
ment has resulted in acceptable early and intermediate
survival. Patients with a small ascending aorta have
emerged as a high-risk group, but a recent technical
modification may improve outcomes in this group of
patients. 
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Discussion
Dr Pedro J. del Nido (Boston, Mass). You have succinctly
identified two of the key features of the standard Norwood
operation that remain problematic—the management of the
diminutive aorta and the use of nonviable tissue as material
for aortic augmentation. 
Your results are very similar to the results from our series
of 194 patients that Dr Daebritz presented last year at this
meeting. The overall survival at 1 year is about 87% in the
most recent patient group. However, there were differences
with respect to risk factors, and I would be interested in your
comments on those differences. 
First, we did not identify ascending aortic size as a risk fac-
tor, although our current technique for the diminutive ascending
aorta is very similar to the one that you described. Is the fact that
you identified the size of the ascending aorta as a risk factor
simply a reflection of the so-called learning curve because you
were trying different techniques? Do you think this will remain
a risk factor now that you are using the reimplantation tech-
nique? Do you think this is an ongoing risk factor? 
Second, we have been concerned about the use of a direct
tissue-to-tissue connection between the MPA trunk or the
neoaortic root and the transverse arch and descending aorta.
That concern stems in part from the potential for left pul-
monary artery compression because of the tension generated.
I noted that balloon dilatation of recoarctation was necessary
in 3 of your patients, so this problem has not been totally
eliminated. However, from the standpoint of growth potential,
there certainly is an advantage. How did you determine
whether there was a maldistribution of pulmonary blood flow
in these patients before the Glenn procedure? Did any of them
have scintigraphy, or did you determine angiographically
whether there was or was not any left pulmonary artery com-
pression? 
Finally, we identified restrictive atrial septal defect as one
of the risk factors for early survival for the first-stage proce-
dure. How many of your patients had a severely restrictive
atrial septal defect, and what is your current management of
these patients? 
Dr Poirier. Thank you, Dr del Nido, for your questions. 
The small ascending aorta has been identified as a risk fac-
tor not only in our group but also in other groups that have
used the patch technique and in those that have used the mod-
ified technique, meaning without the patch. This finding is
not specific to our group. 
Yes, the learning curve of a new procedure contributed to
this mortality. However, the fact that this technique includes
what becomes a small coronary artery might be an intrinsic
part of the anatomy that causes this higher mortality.
Although we were not able to do a multivariate analysis to
identify all the variables that contributed most to the mortal-
ity, I think the anatomy played an important part in this mor-
tality. 
As for determining the pulmonary artery flow, all of the
patients having subsequent procedures underwent angio-
graphic evaluation. At this point, we also measured the pres-
sures, and that is how we determined whether these patients
could undergo CPB and a Fontan operation. More important,
however, all of these patients had their pulmonary arteries
measured in the operating room, even though their pul-
monary anatomy seemed favorable and no obstructions were
apparent. If the size was inadequate, these patients were treat-
ed with an autologous pericardial patch. Thus, the intraoper-
ative investigation was also important. 
We thought about the possibility of the atrial septal defect
being restrictive, but we did not include that in our analysis
of these patients. Actually, we find that a non-critically
restrictive atrial septal defect is beneficial, in that it increases
the pulmonary vascular resistance in these patients preopera-
tively, so that they can be stabilized before being brought into
the operating room, and allows for good systemic perfusion. 
Dr S. Bert Litwin (Milwaukee, Wis). Dr Mee has made
many contributions to the surgical treatment of congenital
heart disease, not the least of which was popularizing the use
of phenoxybenzamine for α-blockade in infants undergoing
complex operations. 
From the Children’s Hospital of Wisconsin, Milwaukee, we
recently reported at another meeting our results with the
Norwood operation in 92 consecutive infants having surgery
from January 1992 through December 1999. We divided
these into two groups, those seen before July 1996 and those
after July 1996. In the latter group, we had added 5 treatment
strategies, including new operative techniques, as described
by Dr Mee, the use of intraoperative aprotinin and modified
ultrafiltration to reduce the inflammatory response to bypass,
α-blockade with phenoxybenzamine, and postoperative mon-
itoring of myocardial oxygen consumption. The difference in
survival was significant, with about a 54% survival in group
I and a 91% survival in group II. Small aortic size was not a
risk factor in our series, although age less than 1 week and
absence of the 5 new treatment strategies were. 
We also used the strategy of manipulating systemic resis-
tance after the operation while maintaining a normal carbon
dioxide tension and ventilatory parameters. Finally, we have
found that monitoring of myocardial oxygen consumption is
the most sensitive measurement of cardiac performance and
oxygen delivery after the Norwood operation.
How did you monitor the degree of α-blockade after the
operation, and what parameters do you use to either increase
or decrease systemic resistance after surgery? 
Dr Poirier. Thank you for your questions. 
We did not use all the techniques that you have described.
However, we did monitor perfusion very closely on the basis
of vital signs, skin temperatures, urine output, serial blood
gases, and more recently, blood lactate levels. With these we
were able to follow our systemic perfusion quite well.
However, we did not use your methods. 
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